MARKET

GMED

GMED

Globus Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

80.72
-0.91
-1.11%
After Hours: 80.72 0 0.00% 18:05 09/17 EDT
OPEN
81.54
PREV CLOSE
81.63
HIGH
81.82
LOW
79.70
VOLUME
1.08M
TURNOVER
--
52 WEEK HIGH
84.23
52 WEEK LOW
48.00
MARKET CAP
8.14B
P/E (TTM)
44.69
1D
5D
1M
3M
1Y
5Y
Cervical Spine Surgery Market- Size and Growth, CAGR Value, Share and Revenues, Industry Trends, Business Strategies and Challenges till 2029
Research Nester released a report titled which delivers detailed overview of the global cervical spine surgery marketin terms of market segmentation by surgery type, end-user and region.
AmericaNewsHour · 09/08 06:26
Globus Medical, Inc.'s (NYSE:GMED) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Globus Medical (NYSE:GMED) has had a great run on the share market with its stock up by a significant 20% over the last...
Simply Wall St. · 09/06 13:20
Globus Medical (GMED) Up 4.9% Since Last Earnings Report: Can It Continue?
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 09/03 15:31
Cervical Spine Surgery Market- Overview, Opportunities, In-Depth Analysis, Segment and Forecast To 2029
Research Nester released a report titled which delivers detailed overview of the global cervical spine surgery marketin terms of market segmentation by surgery type, end-user and region.
AmericaNewsHour · 09/03 13:45
Integral Health Asset Management, LLC Buys Anthem Inc, Biogen Inc, Regeneron Pharmaceuticals ...
GuruFocus News · 08/30 16:38
Return on Capital Employed Insights for Globus Medical
After pulling data from Benzinga Pro it seems like during Q2, Globus Medical (NYSE:GMED) earned $59.75 million, a 8.98% increase from the preceding quarter. Globus Medical also posted a total of $251.02 million in sales, a 10.41% increase since Q1.
Benzinga · 08/20 18:01
WASHINGTON TRUST Co Buys Madison Square Garden Entertainment Corp, Roper Technologies Inc, ...
GuruFocus News · 08/20 16:38
Consonance Capital Management LP Buys Tandem Diabetes Care Inc, Globus Medical Inc, Protagonist ...
GuruFocus News · 08/18 14:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GMED. Analyze the recent business situations of Globus Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GMED stock price target is 85.92 with a high estimate of 100.00 and a low estimate of 55.00.
EPS
Institutional Holdings
Institutions: 410
Institutional Holdings: 70.09M
% Owned: 69.47%
Shares Outstanding: 100.89M
TypeInstitutionsShares
Increased
122
3.06M
New
45
590.83K
Decreased
110
3.08M
Sold Out
37
216.57K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/Executive Director
David Paul
President/Chief Executive Officer/Director
David Demski
Chief Financial Officer/Senior Vice President
Keith Pfeil
Executive Vice President/IR Contact Officer
Daniel Scavilla
Senior Vice President/General Counsel/Secretary
Kelly Huller
Independent Director
David Davidar
Independent Director
Robert Douglas
Independent Director
Daniel Lemaitre
Independent Director
Ann Rhoads
Independent Director
James Tobin
Independent Director
Stephen Zarrilli
No Data
About GMED
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Webull offers kinds of Globus Medical Inc stock information, including NYSE:GMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GMED stock methods without spending real money on the virtual paper trading platform.